GNI GROUP LTD.
Contact Us
About Us
About Us TOP
Message
Business Model
Main Products
Management Policy
Company Overview
Board of Directors
Main Group Structure
Office
Corporate governance
R&D
R&D TOP
Pipeline
Discovery Research
Research publications
Investor Relations
Investor Relations TOP
IR News
Information
IR Materials
IR Calendar
IR Email Subscription
Electronic Public Notices
Sustainability/ESG
Sustainability/ESG TOP
Sustainability Initiatives
ESG Data
Contact Us
Site Map
Privacy Policy
Terms of Use
ソーシャルメディアポリシー
Information
トップページ
Information
All
2026
2025
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2010/05/26
Open-Innovation In Life Science Research and Development
2010/05/01
2010 Nobel-Pauling Biotech Symposium
2010/04/13
Alliance Management Congress
2010/04/12
Notice of Exercise Price of Stock Option etc
2010/03/29
International business and economics TV channel, Nikkei CNBC featured GNI in “Tokyo Market Watch” program, which covers unique venture companies. Dr. Ying Luo (CEO) and Takashi Kataoka (COO) were interviewed about the GNI’s strategy which is to
2010/03/26
Notice of Granting Stock Option to Board of Directors
2010/03/26
Notice of Granting Stock Option to Consultants
2010/03/26
Notice of Granting Stock Option to Employee
2010/03/17
Amendment of Pre-IND Studies of F1013 For Liver Failure Initiated In China And Update On Drug Pipeline Development
2010/03/17
Pharma & Biotech Supply Chain Asia 2010
<
20
21
22
23
24
25
26
27
28
>